These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4094660)

  • 1. Central nervous system supersensitivity and withdrawal from long-term treatment with barbital.
    Sandoval MR; Palermo-Neto J
    Neuropharmacology; 1985 Dec; 24(12):1247-51. PubMed ID: 4094660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABAergic influences on barbital withdrawal induced convulsions.
    Sandoval MR; Palermo-Neto J
    Gen Pharmacol; 1986; 17(4):431-5. PubMed ID: 3758649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of withdrawal from long-term barbital treatment on open-field behaviour and seizure susceptibility of rats.
    Palermo-Neto J; De Lima TC
    Neuropharmacology; 1982 Mar; 21(3):277-81. PubMed ID: 6122187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nervous system supersensitivity and withdrawal from long-term diphenylhydantoin treatment.
    De-Lima TC; Palermo-Neto J
    Braz J Med Biol Res; 1983 Oct; 16(3):241-5. PubMed ID: 6686073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased susceptibility of audiogenic rats to barbital withdrawal convulsions.
    Bourn WM; Garrett RL
    Pharmacol Biochem Behav; 1983 Nov; 19(5):839-41. PubMed ID: 6685882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noradrenergic supersensitivity in the rat vas deferens during barbital withdrawal.
    Saban R; De Moraes S
    Eur J Pharmacol; 1977 May; 43(2):195-8. PubMed ID: 559576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenoceptor supersensitivity in the isolated rat vas deferens during barbital withdrawal.
    Saban R; Capaz FR; De Moraes S
    Eur J Pharmacol; 1982 Aug; 82(1-2):37-45. PubMed ID: 6889970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of delta-9-tetrahydrocannabinol on barbiturate withdrawal convulsions in the rat.
    Gildea ML; Bourn WM
    Life Sci; 1977 Sep; 21(6):829-32. PubMed ID: 562463
    [No Abstract]   [Full Text] [Related]  

  • 9. 2-Amino-7-phosphonoheptanoic acid, a selective antagonist of N-methyl-D-aspartate, prevents barbital withdrawal-induced convulsions and the elevation of cerebellar cyclic GMP in dependent rats.
    McCaslin PP; Morgan WW
    Neuropharmacology; 1987 Jul; 26(7A):731-5. PubMed ID: 2819762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of central monoamine compounds on tranylcypromine-induced barbital-withdrawal convulsions.
    Tagashira E; Hiramori T; Nakao K; Urano T; Yanaura S
    Life Sci; 1983 Apr; 32(14):1599-606. PubMed ID: 6682167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 6-hydroxydopamine pretreatment on spontaneous convulsions induced by barbital withdrawal.
    Morgan WW
    Experientia; 1976 Apr; 32(4):489-91. PubMed ID: 944644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in brain levels of cyclic nucleotides and gamma-aminobutyric acid in barbiturate dependence and withdrawal.
    Lenox RH; Wray HL; Kant GJ; Hawkins TD; Meyerhoff JL
    Eur J Pharmacol; 1979 Apr; 55(2):159-69. PubMed ID: 222596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve growth factor (NGF) in rat brain following long-term barbital treatment: relation to convulsions and cognitive function.
    Wahlström G; Archer T; Lärkfors L
    Neurosci Lett; 1992 Mar; 137(1):65-8. PubMed ID: 1625820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of propranolol on barbital dependence formation and withdrawal signs.
    Tagashira E; Hiramori T; Urano T; Nakao K; Yanaura S
    Jpn J Pharmacol; 1983 Feb; 33(1):133-43. PubMed ID: 6683767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of atropine on the tolerance and the convulsions seen after withdrawal from forced barbital drinking in the rat.
    Wahlström G
    Psychopharmacology (Berl); 1978 Oct; 59(2):123-8. PubMed ID: 103112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response of rat brain protein synthesis to ethanol and sodium barbital.
    Tewari S; Greenberg SA; Do K; Grey PA
    Alcohol Drug Res; 1987; 7(4):243-58. PubMed ID: 3828001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction between electrically induced convulsions and tolerance in the abstinence period after chronic barbital treatments in the rat.
    Wahlström G
    Psychopharmacology (Berl); 1976 Aug; 48(3):239-45. PubMed ID: 823578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of GABAergic drugs on motor impairment from ethanol, barbital and lorazepam in rat lines selected for differential sensitivity to ethanol.
    Hellevuo K; Kiianmaa K; Korpi ER
    Pharmacol Biochem Behav; 1989 Oct; 34(2):399-404. PubMed ID: 2516323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of alcohol and barbital physical dependence.
    Kaneto H; Kawatani S; Kaneda H
    Yakubutsu Seishin Kodo; 1986 Jun; 6(2):267-73. PubMed ID: 3776353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-substitution of diazepam for barbital results in only a low incidence of audiogenic seizures upon withdrawal in dependent rats.
    Reigel CE; Bourn WM
    Proc West Pharmacol Soc; 1994; 37():137-40. PubMed ID: 7984646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.